HEATHER SHOULTZ: Open Payments
NPI 1104557735 · HAMMOND, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$790 in 28 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $491 · 2025 $790
Food & beverage: $790
| Company | Payments | Amount |
|---|---|---|
| MERZ NORTH AMERICA, INC. | 7 | $351 |
| ABBVIE INC. | 10 | $139 |
| Otsuka America Pharmaceutical, Inc. | 1 | $115 |
| Antares Pharma, Inc. | 3 | $67 |
| Novo Nordisk Inc | 3 | $52 |
| Axsome Therapeutics, Inc. | 1 | $18 |
| Lundbeck LLC | 1 | $18 |
| Exact Sciences Corporation | 1 | $15 |
| TOLMAR, INC. | 1 | $14 |
Products named: Xeomin, REXULTI, VRAYLAR, XYOSTED, QULIPTA, Ozempic, Auvelity, The Cologuard Plus Collection Kit.
Industry payments across LA — which companies pay providers there.
